Publications (163) Pablo Pelegrin Vivancos publications View referenced research data.

filter_list

2025

  1. 4-octyl itaconate reduces human NLRP3 inflammasome constitutive activation with the cryopyrin-associated periodic syndrome p.R262W, p.D305N and p.T350M variants

    Cellular and Molecular Life Sciences, Vol. 82, Núm. 1

  2. Gasdermin D mediates a fast transient release of ATP after NLRP3 inflammasome activation before ninjurin 1-induced lytic cell death

    Cell Reports, Vol. 44, Núm. 2

  3. Reusing zebrafish facility equipment: Planning, investment and what we have learned

    Laboratory Animals, Vol. 59, Núm. 1, pp. 40-46

  4. The inflammasome adaptor protein ASC promotes amyloid deposition in cryopyrin-associated periodic syndromes

    EMBO Molecular Medicine

2024

  1. Cell-specific Extracellular Vesicles and Their miRNA Cargo Released Into the Organ Preservation Solution During Cold Ischemia Storage as Biomarkers for Liver Transplant Outcomes

    Transplantation

  2. Detection of inflammasome activation in liver tissue during the donation process as potential biomarker for liver transplantation

    Cell Death Discovery, Vol. 10, Núm. 1

  3. Multiple ASC–dependent inflammasomes drive differential pro-inflammatory cytokine production in a mouse model of tendinopathy

    Bioscience Reports

  4. Ornithine lipid is a partial TLR4 agonist and NLRP3 activator

    Cell Reports, Vol. 43, Núm. 10, pp. 114788

  5. Pathogenic NLRP3 mutants form constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1β production

    Nature Communications, Vol. 15, Núm. 1

  6. The total electric charge and time of application of galvanic currents to macrophages can optimize the release of IL-1β with low cell death

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. ASC oligomer favors caspase-1CARD domain recruitment after intracellular potassium efflux

    The Journal of cell biology, Vol. 222, Núm. 8

  2. Colostrum Features of Active and Recovered COVID-19 Patients Revealed Using Next-Generation Proteomics Technique, SWATH-MS

    Children, Vol. 10, Núm. 8

  3. Comment on: Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3: Reply

    Rheumatology (Oxford, England), Vol. 62, Núm. 5, pp. e168-e169

  4. Danger signals released during cold ischemia storage activate NLRP3 inflammasome in myeloid cells and influence early allograft function in liver transplantation

    eBioMedicine, Vol. 87

  5. Early-onset recurrent panniculitis as a phenotype of NLRC4-associated autoinflammatory syndrome: Characterization of pathogenicity of the p.Ser445Pro NLRC4 variant

    Australasian Journal of Dermatology, Vol. 64, Núm. 2, pp. 260-267

  6. Endothelial cell activation mediated by cold ischemia-released mitochondria is partially inhibited by defibrotide and impacts on early allograft function following liver transplantation

    Biomedicine and Pharmacotherapy, Vol. 167

  7. Evolution of the gasdermin family and pyroptosis

    Developmental and Comparative Immunology, Vol. 149

  8. Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure

    Neurology(R) neuroimmunology & neuroinflammation, Vol. 10, Núm. 3

  9. Measuring IL-1β Processing by Bioluminescence Sensors: Using a Bioluminescence Resonance Energy Transfer Biosensor

    Methods in Molecular Biology (Humana Press Inc.), pp. 47-53

  10. Measuring NLR Oligomerization III: Detection of NLRP3 and NLRC4 Complex by Bioluminescence Resonance Energy Transfer

    Methods in molecular biology (Clifton, N.J.), Vol. 2696, pp. 93-103